Oppenheimer downgraded Sutro Biopharma (STRO) to Perform from Outperform. Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses.

BofA analyst Tazeen Ahmad downgraded Sutro Biopharma (STRO) to Underperform from Buy with a price target of $1, down from $11. Published first on TheFly – the ultimate source for real-time ...

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibrosis and severe ...

GC Biopharma announced on the 14th that it received approval from the Ministry of Food and Drug Safety for the clinical trial plan (IND) for an adult combined vaccine against tetanus, diphtheria ...

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several years – but fell to $1.6 billion across Q2 and Q3 combined ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Toronto, Ontario--(Newsfile Corp. - March 17, 2025) - At the request of the Canadian Investment Regulatory Organization, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

After hours: March 19 at 6:26:25 PM EDT Loading Chart for MREO ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.